At the end of this month, Jill Barnholtz-Sloan, PhD will move on to her new position with the National Cancer Institute (NCI) as Associate Director for Informatics and Data Science, Center for Biomedical Informatics and Information Technology (CBIIT) and she will become an intramural researcher in the Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program. We all congratulate this step up onto the national stage at NCI and know she will represent us well.
Jill has been with the Case Comprehensive Cancer Center since 2007. She will be missed for her many extraordinary accomplishments here, including branding an innovative approach to data science, her dedication to brain tumor research (including a recently awarded P01) and serving as an exemplary model of female leadership. Her roles across the cancer center, Department of Population and Quantitative Health Sciences, with University Hospitals and university service have all been high impact.
Jill is an exceptional leader of cancer data science. She is a model team scientist and biostatistical/bioinformatics expert, translating pressing questions into rigorous studies that inform clinical care and population health. At the Case Comprehensive Cancer Center, Jill links investigators through cross-institutional efforts in critical thinking and data analytics as Associate Director for Data Sciences. She is also Associate Director for Translational Informatics, Cleveland Institute for Computational Biology, Case Western Reserve University (CWRU); Director for Research Health Analytics and Informatics, University Hospitals; Director, Cleveland Center for Health Outcomes Research; and a tenured professor in the CWRU Department of Population and Quantitative Health Sciences and holds the Sally S. Morley Designated Professorship/Chair in recognition of her excellence in brain tumor research.
Nationally, Jill is well known to the NCI. She has served as a disease expert on the NCI The Cancer Genome Atlas (TCGA) brain tumor-related working groups and is Co-chair of the NCI Clinical Proteomic Tumor Analysis Consortium (CPTAC) glioblastoma expert committee. Additionally, she serves on advisory boards for multiple brain tumor foundations in the United States and is an associate editor or member of the editorial board for multiple peer-reviewed journals. Jill has served as an expert peer reviewer for National Institute of Health study sections.
Internationally, Jill was a founding board member of the Brain Tumor Epidemiology Consortium (BTEC) in 2003 and was elected Co-Vice President and Co-President from 2010-2014. Under her leadership, the consortium published three landmark review papers in brain tumor epidemiology.
Personally, Jill is known for her warm heart and love of chocolate and cake. She is generous with kind words of thanks for those around her, has been an insightful and tireless mentor and an exacting reviewer and assessor of research projects and talent. Jill makes every attempt to know people personally – whether a high-level leader or a student in a lab.
Jill has made a significant impact on our center over the past 14 years and will continue her research collaborations with us, hopefully for many years to come. We look forward to having another friend at the National Institutes of Health. We wish Jill the best of luck in her new endeavor.
Stan Gerson, MD
Director, Case Comprehensive Cancer Center